DMAA
NASDAQ · N/A
Drugs Made In America Acquis
$10.89
+0.01 (+0.09%)
Open$10.89
Previous Close$10.88
Day High$10.89
Day Low$10.89
52W High$10.89
52W Low$10.26
Volume—
Avg Volume840
Market Cap264.38M
P/E Ratio43.38
EPS$0.21
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 219.69M | 205.61M | 216.54M |
| Net Income | 25.03M | 23.39M | 21.58M |
| Profit Margin | 11.4% | 11.4% | 10.0% |
| EBITDA | 37.03M | 38.19M | 42.37M |
| Free Cash Flow | 19.51M | 14.22M | 14.32M |
| Rev Growth | -5.7% | -2.0% | +21.2% |
| Debt/Equity | 0.87 | 0.86 | 1.14 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $2.07 | -3.94% | — | 1.28B |
| PICS | Pics Nv | $8.97 | +6.41% | 4.6 | 1.18B |
| DMII | Drugs Made In America Acquis | $10.19 | +0.00% | 49.9 | 649.10M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.70 | +0.19% | 42.2 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.27 | +0.00% | 41.3 | 586.93M |